ESI 09
![]() |
- ₹14267.35 - ₹58054.48
- Product name: ESI 09
- CAS: 263707-16-0
- MF: C16H15ClN4O2
- MW: 330.77
- EINECS:
- MDL Number:MFCD00109218
- Synonyms:ESI 09;ESI09;ESI-09;(E)-3-(5-tert-butylisoxazol-3-yl)-2-(2-(3-chlorophenyl)hydrazono)-3-oxopropanenitrile;α-[2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-b-oxo-3-isoxazolepropanenitrile;alpha-[(3-Chlorophenyl)hydrazono]-5-(1,1-dimethylethyl)-beta-oxo-3-isoxazolepropanenitrile;α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile;3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 5MG
- 25MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML0814
- Product descriptionESI-09 ≥98% (HPLC)
- Packaging5MG
- Price₹14267.35
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML0814
- Product descriptionESI-09 ≥98% (HPLC)
- Packaging25MG
- Price₹58054.48
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML0814 | ESI-09 ≥98% (HPLC) | 5MG | ₹14267.35 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML0814 | ESI-09 ≥98% (HPLC) | 25MG | ₹58054.48 | 2022-06-14 | Buy |
Properties
Melting point :>175°C (dec.)
storage temp. :2-8°C
solubility :DMSO: soluble20mg/mL, clear
form :powder
color :, faint yellow to dark orange
storage temp. :2-8°C
solubility :DMSO: soluble20mg/mL, clear
form :powder
color :, faint yellow to dark orange
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Exchange protein activated by cAMP (Epac) proteins mediate cAMP signaling independent of protein kinase A (PKA). ESI-09 is an inhibitor of Epac1 and Epac2 with IC50 values of 3.2 and 1.4 μM, respectively. It shows no activity against PKA at concentrations as high as 25 μM. ESI-09 has been shown to block Akt phosphorylation and insulin secretion in pancreatic β cells, as well as to block the migration of AsPC-1 and PANC-1 pancreatic cancer cells in vitro.Related product price
- FORSKOLIN
₹9693-97793.05 - bupivacaine hydrochloride
₹5500-15600 - Cilomilast
₹17157.63-69648.05